SSP
MED icon

Sapphire Star Partners’s Medifast MED Stock Holding History

Sapphire Star Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$770K Buy
6,166
+2,540
+70% +$434K 1.03% 31
2018
Q3 		$804K Buy
+3,626
New +$735K 0.81% 44

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sapphire Star Partners's MED Position: Q4 2018 in Review

Sapphire Star Partners increased its Medifast (MED) stake by 70% in Q4 2018, buying an estimated $434K and bringing the position to 6,166 shares worth $770K. The position accounts for 1.03% of the portfolio, ranked #31.

Sapphire Star Partners first reported a position in MED in Q3 2018 and has held it in 2 quarters since. The position peaked at $804K in Q3 2018. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

  • Sapphire Star Partners held 6,166 shares of Medifast worth $770K as of Q4 2018.
  • Sapphire Star Partners bought 2,540 Medifast shares in Q4 2018, an estimated $434K.
  • Medifast made up 1.03% of Sapphire Star Partners's portfolio in Q4 2018, its #31 holding.
  • Sapphire Star Partners first reported a position in Medifast in Q3 2018 and has held it in 2 quarters since.
  • Sapphire Star Partners's Medifast position peaked at $804K in Q3 2018.
  • 247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Sapphire Star Partners's 13F filing for Q4 2018, filed 12 Feb 2019.